O

Oric Pharmaceuticals
D

ORIC

9.80000
USD
-0.11
(-1.11%)
مفتوح الان
حجم التداول
12,792
الربح لكل سهم
-2
العائد الربحي
-
P/E
-5
حجم السوق
691,556,110
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BXRX
    0
    (0%)
    0.000000 USD
    F
    FULC
    -0.32000
    (-9.64%)
    3.00000 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    S
    SG
    -0.150
    (-0.45%)
    33.520 USD
    S
    STRA
    -1.000
    (-1.03%)
    95.650 USD
    V
    VCYT
    -1.085
    (-2.93%)
    35.955 USD
    V
    VRTV
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Oric Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.